Acta Vet. Brno 2006, 75: 549-555

https://doi.org/10.2754/avb200675040549

Fexofenadine Treatment of Atopic Dogs: Preliminary Clinical Results

A. Plevnik1, T. Kotnik2, S. Kobal3

1Aventis Pharma d.o.o. Ljubljana, Slovenia
2Small Animal Clinic, Veterinary Faculty, University of Ljubljana, Slovenia
3Institute of Physiology, Pharmacology and Toxicology, Veterinary Faculty, University of Ljubljana, Slovenia

Received January 6, 2006
Accepted June 30, 2006

Crossref Cited-by Linking

  • Oh Su-Jeong, Nguyen Tiep Tien, Seo Yoojin, Park Hee-Jeong, Ahn Ji-Su, Shin Ye Young, Kang Byung-Jae, Jang Min, Park Junhyeung, Jeong Jee-Heon, Kim Hyung-Sik: Sustained release of stem cell secretome from nano-villi chitosan microspheres for effective treatment of atopic dermatitis. International Journal of Biological Macromolecules 2024, 277, 134344. <https://doi.org/10.1016/j.ijbiomac.2024.134344>
  • Bruet Vincent, Mosca Marion, Briand Amaury, Bourdeau Patrick, Pin Didier, Cochet-Faivre Noëlle, Cadiergues Marie-Christine: Clinical Guidelines for the Use of Antipruritic Drugs in the Control of the Most Frequent Pruritic Skin Diseases in Dogs. Veterinary Sciences 2022, 9, 149. <https://doi.org/10.3390/vetsci9040149>
  • Sader Safaa, Cai Jun, Muller Anna C.G., Wu Chun: Can human allergy drug fexofenadine, an antagonist of histamine (H1) receptor, be used to treat dog and cat? Homology modeling, docking and molecular dynamic Simulation of three H1 receptors in complex with fexofenadine. Journal of Molecular Graphics and Modelling 2017, 75, 106. <https://doi.org/10.1016/j.jmgm.2017.05.010>
  • SINGH S. K., DIMRI U., SAXENA S. K., JADHAV R. K.: Therapeutic management of canine atopic dermatitis by combination of pentoxifylline and PUFAs. Vet Pharm & Therapeutics 2010, 33, 495. <https://doi.org/10.1111/j.1365-2885.2009.01146.x>
Crossref Cited-by Linking logo